Treatment of Oropharyngeal Symptoms: A Prospective, Single-Dose, Placebo-Controlled, Randomized Clinical Trial

Open Access Journal of Clinical Trials · Published 2022-03-01 · DOI 10.2147/oajct.s331883

Authors being retrieved — see the publisher record. https://doi.org/10.2147/oajct.s331883

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2022

Related articles

• The European Medicines Agency Clinical Data Website Enables Insights Into Clinical Development Timelines And Strategy · Open Access Journal of Clinical Trials · 2019 · Same journal
• Conducting clinical trials in emerging markets of sub-Saharan Africa: review of guidelines and resources for foreign sponsors · Open Access Journal of Clinical Trials · 2015 · Same journal
• On controversial statistical issues in clinical research · Open Access Journal of Clinical Trials · 2015 · Same journal
• Protocol-writing support conferences for investigator-initiated clinical trials · Open Access Journal of Clinical Trials · 2016 · Same journal
• Effects of pain on cognitive function and mobility · Open Access Journal of Clinical Trials · 2019 · Same journal
• Terminated Interventional Trials in the Clinical Trial Registry of India Database: An Analysis to Evaluate the Reasons for Termination · Open Access Journal of Clinical Trials · 2020 · Same journal
• Evaluation of medication errors with implementation of electronic health record technology in the medical intensive care unit · Open Access Journal of Clinical Trials · 2017 · Same journal
• Deep brain stimulation targeting the fornix for mild Alzheimer dementia: design of the ADvance randomized controlled trial · Open Access Journal of Clinical Trials · 2015 · Same journal
• Informing primary care physicians of patients' involvement in clinical trials carried out at a specialist care level · Open Access Journal of Clinical Trials · 2017 · Same journal
• Neuropsychiatric symptoms in dementia and the effects of Ginkgo biloba extract EGb 761® treatment: additional results from a 24-week randomized, placebo-controlled trial · Open Access Journal of Clinical Trials · 2016 · Same journal